Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 244

1.

[Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].

Bijlsma JW, Lems WF, van de Laar MA.

Ned Tijdschr Geneeskd. 2007 Apr 7;151(14):795-8. Dutch.

PMID:
17469317
[PubMed - indexed for MEDLINE]
2.

Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Savage R.

Drugs Aging. 2005;22(3):185-200. Review.

PMID:
15813652
[PubMed - indexed for MEDLINE]
3.
4.

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72.

PMID:
17086563
[PubMed - indexed for MEDLINE]
5.

Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):223-7.

PMID:
18084859
[PubMed - indexed for MEDLINE]
6.

Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor.

Bannwarth B, Berenbaum F.

Expert Opin Investig Drugs. 2005 Apr;14(4):521-33. Review.

PMID:
15882125
[PubMed - indexed for MEDLINE]
7.

The use of NSAIDs in rheumatic disorders 2005: a global perspective.

Kean WF, Buchanan WW.

Inflammopharmacology. 2005;13(4):343-70. Review.

PMID:
16354389
[PubMed - indexed for MEDLINE]
8.

[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].

Valat JP, Deray G, Héloire F.

Presse Med. 2006 Sep;35 Suppl 1:25-34. Review. French.

PMID:
17870550
[PubMed - indexed for MEDLINE]
9.

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.

Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J.

Drug Saf. 2006;29(7):621-32.

PMID:
16808554
[PubMed - indexed for MEDLINE]
10.

Anti-inflammatory drugs in the 21st century.

Rainsford KD.

Subcell Biochem. 2007;42:3-27. Review.

PMID:
17612044
[PubMed - indexed for MEDLINE]
12.
13.

[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].

Valat JP, Deray G, Héloire F.

Presse Med. 2006 Sep;35(9 Spec No 1):1S25-34. Review. French.

PMID:
17078592
[PubMed - indexed for MEDLINE]
14.

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials.

Curtis SP, Ng J, Yu Q, Shingo S, Bergman G, McCormick CL, Reicin AS.

Clin Ther. 2004 Jan;26(1):70-83.

PMID:
14996519
[PubMed - indexed for MEDLINE]
15.
16.

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.

van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM.

Ann Rheum Dis. 2009 May;68(5):668-73. doi: 10.1136/ard.2007.087254. Epub 2008 May 21.

PMID:
18495734
[PubMed - indexed for MEDLINE]
17.

How to advise aspirin use in patients who need NSAIDs.

Sopena F, Lanas A.

Curr Pharm Des. 2007;13(22):2248-60. Review.

PMID:
17691998
[PubMed - indexed for MEDLINE]
18.

Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.

Johnell K, Fastbom J.

Clin Drug Investig. 2008;28(11):687-95.

PMID:
18840011
[PubMed - indexed for MEDLINE]
19.

Cardiovascular issues of COX-2 inhibitors and NSAIDs.

Wong M, Chowienczyk P, Kirkham B.

Aust Fam Physician. 2005 Nov;34(11):945-8. Review.

PMID:
16299629
[PubMed - indexed for MEDLINE]
Free Article
20.

[Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].

van den Bemt BJ, Benraad HB, Rasker JJ.

Ned Tijdschr Geneeskd. 2007 May 12;151(19):1062-7. Review. Dutch.

PMID:
17552414
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk